Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4

Severe hepatitis-hydropericardium syndrome (HHS) associated with a novel viral genotype, fowl adenovirus 4 (FAdV-4), has emerged and widely spread in China since 2015, causing severe economic losses to the poultry industry. We previously reported that the hexon gene is responsible for pathogenicity...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qing Pan, Yu Zhang, Aijing Liu, Hongyu Cui, Yulong Gao, Xiaole Qi, Changjun Liu, Yanping Zhang, Kai Li, Li Gao, Xiaomei Wang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
HHS
Acceso en línea:https://doaj.org/article/3dc0aaf604fa4c408014eefaf33bc9f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3dc0aaf604fa4c408014eefaf33bc9f6
record_format dspace
spelling oai:doaj.org-article:3dc0aaf604fa4c408014eefaf33bc9f62021-12-01T23:20:42ZDevelopment of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 41664-302X10.3389/fmicb.2021.780978https://doaj.org/article/3dc0aaf604fa4c408014eefaf33bc9f62021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmicb.2021.780978/fullhttps://doaj.org/toc/1664-302XSevere hepatitis-hydropericardium syndrome (HHS) associated with a novel viral genotype, fowl adenovirus 4 (FAdV-4), has emerged and widely spread in China since 2015, causing severe economic losses to the poultry industry. We previously reported that the hexon gene is responsible for pathogenicity and obtained a non-pathogenic hexon-replacement rHN20 strain; however, the lack of information about the non-essential regions for virus replication limits the development of a FAdV-4 vector. This study first established an enhanced green fluorescent protein (EGFP)-indicator virus based on the FAdV-4 reverse genetic technique, effective for batch operations in the virus genome. Based on this, 10 open reading frames (ORFs) at the left end and 13 ORFs at the right end of the novel FAdV-4 genome were deleted separately and identified as non-essential genes for viral replication, providing preliminary insertion sites for foreign genes. To further improve its feasibility as a vaccine vector, seven combinations of ORFs were successfully replaced with EGFP without affecting the immunogenicity of the vector backbone. Finally, a recombinant rHN20-vvIBDV-VP2 strain, expressing the VP2 protein of very virulent infectious bursa disease virus (vvIBDV), was rescued and showed complete protection against FAdV-4 and vvIBDV. Thus, the novel FAdV-4 vector could provide sufficient protection for HHS and efficient exogenous gene delivery. Overall, our findings systemically identified 23 non-essential ORFs for FAdV-4 replication and seven foreign gene insertion regions, providing valuable information for an in-depth understanding of the novel FAdV-4 pathogenesis and development of multivalent vaccines.Qing PanYu ZhangAijing LiuHongyu CuiYulong GaoXiaole QiChangjun LiuYanping ZhangKai LiLi GaoXiaomei WangXiaomei WangFrontiers Media S.A.articleFAdV-4vaccine vectorHHSnon-essential regionsIBDVMicrobiologyQR1-502ENFrontiers in Microbiology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic FAdV-4
vaccine vector
HHS
non-essential regions
IBDV
Microbiology
QR1-502
spellingShingle FAdV-4
vaccine vector
HHS
non-essential regions
IBDV
Microbiology
QR1-502
Qing Pan
Yu Zhang
Aijing Liu
Hongyu Cui
Yulong Gao
Xiaole Qi
Changjun Liu
Yanping Zhang
Kai Li
Li Gao
Xiaomei Wang
Xiaomei Wang
Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4
description Severe hepatitis-hydropericardium syndrome (HHS) associated with a novel viral genotype, fowl adenovirus 4 (FAdV-4), has emerged and widely spread in China since 2015, causing severe economic losses to the poultry industry. We previously reported that the hexon gene is responsible for pathogenicity and obtained a non-pathogenic hexon-replacement rHN20 strain; however, the lack of information about the non-essential regions for virus replication limits the development of a FAdV-4 vector. This study first established an enhanced green fluorescent protein (EGFP)-indicator virus based on the FAdV-4 reverse genetic technique, effective for batch operations in the virus genome. Based on this, 10 open reading frames (ORFs) at the left end and 13 ORFs at the right end of the novel FAdV-4 genome were deleted separately and identified as non-essential genes for viral replication, providing preliminary insertion sites for foreign genes. To further improve its feasibility as a vaccine vector, seven combinations of ORFs were successfully replaced with EGFP without affecting the immunogenicity of the vector backbone. Finally, a recombinant rHN20-vvIBDV-VP2 strain, expressing the VP2 protein of very virulent infectious bursa disease virus (vvIBDV), was rescued and showed complete protection against FAdV-4 and vvIBDV. Thus, the novel FAdV-4 vector could provide sufficient protection for HHS and efficient exogenous gene delivery. Overall, our findings systemically identified 23 non-essential ORFs for FAdV-4 replication and seven foreign gene insertion regions, providing valuable information for an in-depth understanding of the novel FAdV-4 pathogenesis and development of multivalent vaccines.
format article
author Qing Pan
Yu Zhang
Aijing Liu
Hongyu Cui
Yulong Gao
Xiaole Qi
Changjun Liu
Yanping Zhang
Kai Li
Li Gao
Xiaomei Wang
Xiaomei Wang
author_facet Qing Pan
Yu Zhang
Aijing Liu
Hongyu Cui
Yulong Gao
Xiaole Qi
Changjun Liu
Yanping Zhang
Kai Li
Li Gao
Xiaomei Wang
Xiaomei Wang
author_sort Qing Pan
title Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4
title_short Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4
title_full Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4
title_fullStr Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4
title_full_unstemmed Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4
title_sort development of a novel avian vaccine vector derived from the emerging fowl adenovirus 4
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/3dc0aaf604fa4c408014eefaf33bc9f6
work_keys_str_mv AT qingpan developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT yuzhang developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT aijingliu developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT hongyucui developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT yulonggao developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT xiaoleqi developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT changjunliu developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT yanpingzhang developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT kaili developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT ligao developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT xiaomeiwang developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
AT xiaomeiwang developmentofanovelavianvaccinevectorderivedfromtheemergingfowladenovirus4
_version_ 1718403978715201536